A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF INCB000928 IN PARTICIPANTS WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
- Registry ID
- INCB 00928-201
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Phase
- PHASE2
- Study type
- INTERVENTIONAL
- Sponsor
- INCYTE CORPORATION
- Start date
- 2024-03-02
- Last update
- 2021-11-25
Conditions
- FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP)
View on source registry